Walleye Trading LLC Ultragenyx Pharmaceutical Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$31.73 - $49.19 $175,625 - $272,266	-5,535 Reduced 37.79%	9,113 $435,000
Q3 2023 Nov 14, 2023	BUY	$34.92 - $46.66 $501,032 - $669,477	14,348 Added 4782.67%	14,648 $522,000
Q2 2023 Aug 14, 2023	BUY	$37.35 - $52.15 $11,205 - $15,645	300 New	300 $13,000
Q1 2022 May 16, 2022	BUY	$62.2 - $84.4 $1.06 Million - $1.43 Million	16,982 Added 411.88%	21,105 $1.53 Million
Q4 2021 Feb 14, 2022	BUY	$73.71 - $87.86 $303,906 - $362,246	4,123 New	4,123 $347,000
Q2 2021 Aug 16, 2021	SELL	$92.19 - $115.71 $95,232 - $119,528	-1,033 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$106.9 - $167.73 $1.48 Million - $2.32 Million	-13,816 Reduced 93.04%	1,033 $118,000
Q4 2020 Feb 16, 2021	BUY	$84.4 - $177.39 $1.25 Million - $2.63 Million	14,849 New	14,849 $2.06 Million

325

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.